Pharmacology

A list of available treatments for screwworm infestations in cattle, horses, sheep, goats, deer, swine, cats, dogs, exotic, zoo, and wildlife species, as well as guidance for practitioners before using these products.

The supplemental approval expands KetoMed's existing label to include a new species and indication, offering veterinarians a generic alternative to the brand-name Ketofen.

The agency is encouraging sponsors of animal drugs for minor use in minor species (MUMS) who meet the eligibility requirements, or their research partners, to apply.

Jennifer Miller, DVM, talks about pharmacology innovation and new therapies for canine parvovirus and itch relief.

Zoetis' doramectin injection is now indicated for use in dairy cows, horses, sheep, swine, and deer to help mitigate NWS myiasis.

CosACTHen by Dechra is indicated for the evaluation of adrenal function in dogs.

Tirnovetmab (Befrena; Elanco) injection received USDA approval in late 2025.

The European Medicines Agency has recommended Nobivac NXT HCPChFelV for market authorization in the European Union.

Pregabalin chewable tablets target nerve-related pain by reducing the release of neurotransmitters involved in pain signaling within the spinal cord.

New research and treatment methods are finding ways to combat the parasitic Varroa mite to save colonies from collapsing.

The FDA's approval of tasipimidine oral solution (Tessie) marks the first time a single product has received federal clearance for both noise aversion and separation anxiety in dogs.

The oral moxidectin therapy is available over the counter.

After years of off-label use, veterinarians now have the first FDA-approved amlodipine formulation specifically indicated for cats with systemic hypertension.

The virtual sessions will address the Animal Drug User Fee Act and Animal Generic Drug User Fee Act.

The authorization adds to a growing list of treatments cleared under emergency use as federal agencies ramp up efforts to prevent New World screwworm from reestablishing in the United States.

Mixlab and Instinct are collaborating to assist veterinarians with prescription ordering and workflow efficiency.

New study results from Gallant show that 76% of cats improved after receiving intravenous uterine-derived mesenchymal stromal cell therapy, an immune-modulating treatment that doesn't require patient-derived cells.

Boehringer Ingelheim will have the therapy available in several European countries by the end of April 2026.

The medetomidine threat is serious, and veterinary professionals can help mitigate risk by taking action to keep a problem from arising in their facilities.

A professional overview of compounding's role in modern medicine and the regulations that govern it.

The product by Bimeda Animal Health is a proton pump inhibitor.

nixiFLOR by Parnell Technologies is the first therapy approved by the FDA as a bioequivalent to Resflor Gold (Merck Animal Health).

The author, a veterinary medical advisor for Biogal Labs, clarifies common misconceptions.

A small prospective study suggests dapagliflozin is well tolerated in dogs with heart disease and may influence oxidative biomarkers, though a clear natriuretic effect was not observed.

A puppy was brought to DoveLewis Veterinary Emergency & Specialty Hospital in Oregon after ingesting a toxic dose of carprofen.